Anti-Ebola MVA vaccine produced on ProBioGen’s AGE1.CR cell line platform enters clinical trials
3 June 2015 | By Victoria White
An investigational vaccine against Ebola, produced on ProBioGen’s proprietary, continuous muscovy duck AGE1.CR cell line, has proceeded into clinical trials...